Patient perception of voxelotor treatment benefit in sickle cell disease

Patients with sickle cell disease (SCD) experience a range of clinical symptoms, including acute and chronic pain, fatigue, and respiratory problems, as well as chronic organ complications that can lead to disability and accelerated mortality. Voxelotor is a first-in-class therapy that targets sickl...

Descripción completa

Detalles Bibliográficos
Autores principales: Idowu, Modupe, Haque, Anam, Williams, Elisa M, Sridhar, Arthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240335/
https://www.ncbi.nlm.nih.gov/pubmed/35732337
http://dx.doi.org/10.1136/jim-2021-002215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240335/
https://www.ncbi.nlm.nih.gov/pubmed/35732337
http://dx.doi.org/10.1136/jim-2021-002215

Ejemplares similares